Trump: We May Have a Deal on Gaza
Lib Reporter Drops the Most Insane Line About Latino Kids and ICE
'Hypocrisy on Steroids': Kash Patel Torches Media Over Comey Indictment
Foreigners Who Mocked Kirk’s Death Might Soon Regret It
Alvin Bragg's Office Quietly Dismissed Charges Against Woman Who Assaulted Pro-Life Activi...
Sean Duffy Announces New Emergency Rules to Overhaul CDL Eligibility
JD Vance Demands Jimmy Kimmel Apologize to Erika Kirk Following His Return to...
Georgetown Students React to Flyers Glorifying Charlie Kirk’s Assassination
Jeffries Vows Anyone Involved in Comey Indictment 'Will Face Accountability'
Inflation Data for August Is in...
Comey Posted a Video After Indictment. Here's What He Had to Say.
Trump Announces Slew of New Tariffs
Theo Von's Objection to DHS Using Him in Video Spurs Debate
Why I Cannot Forgive Charlie Kirk's Murderer
Britain's Two-Tier Policing and Enforcement Regime Is Outrageous and Undeniable
Tipsheet

Here's Why Moderna Just Filed a Lawsuit Against Pfizer/BioNTech

AP Photo/Rogelio V. Solis

Moderna filed a lawsuit on Friday against competitors Pfizer and BioNTech, alleging copyright infringement over the COVID-19 mRNA vaccines.

The company claims its competitors’ Comirnaty vaccine “unlawfully infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology,” according to a press release. 

Advertisement

"We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic," said Moderna Chief Executive Officer Stéphane Bancel. "This foundational platform, which we began building in 2010, along with our patented work on coronaviruses in 2015 and 2016, enabled us to produce a safe and highly effective COVID-19 vaccine in record time after the pandemic struck.”

Moderna said because of its commitment to ensuring global access to vaccines, it decided against pursuing legal action during the height of the pandemic. As of March 2022, however, when the fight against COVID-19 “entered a new phase” and vaccine availability was no longer an issue in many parts of the world, its pledge had been updated. 

"We believe that Pfizer and BioNTech unlawfully copied Moderna's inventions, and they have continued to use them without permission," said Moderna Chief Legal Officer Shannon Thyme Klinger. "Outside of the [92 low and middle-income countries in the GAVI COVAX Advance Market Commitment], where vaccine supply is no longer a barrier to access, Moderna expects Pfizer and BioNTech to compensate Moderna for Comirnaty®'s ongoing use of Moderna's patented technologies. Our mission to create a new generation of transformative medicines for patients by delivering on the promise of mRNA science cannot be achieved without a patent system that rewards and protects innovation."

Advertisement

The company said it is not looking to take Comirnaty off the market, nor is it seeking an injunction to stop future sales. Furthermore, Moderna is not seeking damages for activities prior to March 8, 2022.

A Pfizer spokesperson told Reuters the company was "surprised" by the legal challenge.

"Pfizer/BioNTech has not yet fully reviewed the complaint but we are surprised by the litigation given the COVID-19 vaccine was based on BioNTech's proprietary mRNA technology and developed by both BioNTech and Pfizer."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement